Suchergebnisse - "Nair, Manoj S"

PubPharm (14)

1

An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo

enthalten in: Nature communications | 2023

von Tsuji, M. | Nair, M. | Masuda, K. | +15

2

An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses

enthalten in: Science translational medicine | 2022

von Liu, L. | Iketani, S. | Guo, Y. | +28

3

Defining the risk of SARS-CoV-2 variants on immune protection

enthalten in: Nature | 2022

von DeGrace, M. | Ghedin, E. | Frieman, M. | +98

4

An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection

enthalten in: Cell reports | 2021

von Duan, X. | Tang, X. | Nair, M. | +11

CommentIn: J Mol Cell Biol. 2022 Feb 24;14(1):. - PMID 34850919

5

Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses

enthalten in: Cell reports | 2021

von Banach, B. | Cerutti, G. | Fahad, A. | +31

UpdateOf: bioRxiv. 2021 Jan 03;:. - PMID 33442681

6

Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2021

von King, H. | Joyce, M. | Lakhal-Naouar, I. | +54

UpdateOf: bioRxiv. 2021 Apr 10;:. - PMID 33851155

7

Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants

enthalten in: Nature | 2021

von Xu, J. | Xu, K. | Jung, S. | +27

UpdateOf: bioRxiv. 2021 Mar 04;:. - PMID 33688659

8

Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity

enthalten in: Journal of virology | 2021

von Resnick, S. | Iketani, S. | Hong, S. | +15

9

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

enthalten in: Cell host & microbe | 2021

von Cerutti, G. | Guo, Y. | Zhou, T. | +20

CommentIn: Cell Host Microbe. 2021 May 12;29(5):744-746. - PMID 33984277

10

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

enthalten in: Nature communications | 2021

von Iketani, S. | Forouhar, F. | Liu, H. | +9

UpdateOf: bioRxiv. 2020 Aug 04;:. - PMID 32793898